Cole Eye Institute Outcomes

Because Cole Eye Institute is a tertiary care center, patients referred for surgery often have multiple, simultaneous eye diseases that can influence visual potential and limit the ability to predict precise refractive outcome. These comorbidities may explain the limited visual improvement in some patients. Among patients undergoing cataract surgery at the institute in 2022, there were no comorbidities in 71.5% of patients; comorbidities affecting retina (9.1%) and glaucoma (8.0%) were most common, followed by cornea (4.9%), postrefractive surgery (2.1%), and other, which included uveitis and lens (4.3%).